GT
TMDX icon

Glenmede Trust’s Transmedics TMDX Stock Holding History

Glenmede Trust’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,489
Closed -$548K – 1459
2024
Q3 		$548K Buy
3,489
+81
+2% +$12.5K ﹤0.01% 909
2024
Q2 		$513K Sell
3,408
-707
-17% -$84.8K ﹤0.01% 896
2024
Q1 		$304K Sell
4,115
-1,287
-24% -$106K ﹤0.01% 1054
2023
Q4 		$426K Buy
+5,402
New +$326K ﹤0.01% 945
2023
Q3 		– Sell
-3,867
Closed -$293K – 1365
2023
Q2 		$293K Hold
3,867
– – ﹤0.01% 996
2023
Q1 		$293K Buy
+3,867
New +$267K ﹤0.01% 1001
2022
Q3 		– Sell
-14,249
Closed -$448K – 1330
2022
Q2 		$448K Sell
14,249
-7,706
-35% -$205K ﹤0.01% 887
2022
Q1 		$591K Buy
21,955
+450
+2% +$8.06K ﹤0.01% 845
2021
Q4 		$412K Buy
21,505
+7,479
+53% +$187K ﹤0.01% 976
2021
Q3 		$464K Buy
+14,026
New +$429K ﹤0.01% 920

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Glenmede Trust's TMDX Position: Q4 2024 in Review

Glenmede Trust sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 3,489 shares — an estimated $548K sold.

Glenmede Trust first reported a position in TMDX in Q3 2021 and held it in 10 quarters. The position peaked at $591K in Q1 2022. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • Glenmede Trust reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • Glenmede Trust sold 3,489 Transmedics shares in Q4 2024, an estimated $548K.
  • Glenmede Trust first reported a position in Transmedics in Q3 2021 and held it in 10 quarters.
  • Glenmede Trust's Transmedics position peaked at $591K in Q1 2022.
  • 315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Glenmede Trust's 13F filing for Q4 2024, filed 14 Feb 2025.